Skip to content

Author

E. Savarino

7 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Diagnostic Accuracy of High‐Resolution Manometry for Assessing Fundoplication Integrity: Validation of the Padova Classification

Recurrent symptoms after laparoscopic fundoplication (LF) are not fully understood, with ongoing research focusing on their mechanisms. This study aimed to validate the Padova Classification, a postoperative high‐resolution manometry (HRM) framework to distinguish functioning from defective fundoplications.

A. Vittori, G. Capovilla, M. Santangelo et al. · 1 citation
Review Open access Oct 2026

Impact of Obesity and Its Treatment on Inflammatory Bowel Disease Outcomes: A Narrative Review

Obesity is a chronic inflammatory condition whose rising incidence has turned it into a global epidemic, a trend that also affects people living with inflammatory bowel diseases (IBD). Recent epidemiological data indicate that roughly 25 to 40% of patients with IBD are overweight and that 15 to 40% have obesity. Obesit...

Carlo Redavid, Pietro Pirro, Luisa Bertin et al. · 0 citations
Review Open access Sep 2026

The Role of Diet in Functional Dyspepsia

Functional dyspepsia (FD) is a disorder of gut–brain interaction affecting approximately 7% of the global population under Rome IV criteria, characterised by postprandial fullness, early satiation, epigastric pain, and/or epigastric burning in the absence of identifiable organic disease. Meal ingestion is the dominant...

Luisa Bertin, C. Van de Bruaene, E. Formisano et al. · 0 citations
Review Open access Oct 2026

Dietary and Parenteral Nutritional Management of Short Bowel Syndrome with Intestinal Failure in Adults: A Narrative Review

A practical, physiology-anchored approach that maximises enteral autonomy and quality of life while preventing the metabolic, hepatic and catheter-related complications of long-term intravenous feeding is proposed.

B. Barberio, Beatrice Varotto, Matteo D'Angelo et al. · 0 citations
Open access Sep 2026

Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

Upadacitinib was effective and well-tolerated in AT-experienced Crohn's disease, including patients with active EIMs, with induction benefit maintained through 6 months without novel safety signals.

B. Barberio, F. D'Amico, L. Laterza et al. · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.